Last reviewed · How we verify
Second Treatment Period
Second treatment period is a type of therapy that involves a second round of treatment for a medical condition.
Second treatment period is a type of therapy that involves a second round of treatment for a medical condition. Used for Treatment of various medical conditions.
At a glance
| Generic name | Second Treatment Period |
|---|---|
| Sponsor | Beth Israel Deaconess Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
The exact mechanism of second treatment period is not well-documented, but it is thought to involve a continuation of the initial treatment regimen with adjustments as needed.
Approved indications
- Treatment of various medical conditions
Common side effects
- Unknown
Key clinical trials
- Bevacizumab In Hereditary Hemorrhagic Telangiectasia (PHASE2)
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters (PHASE2)
- Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma (PHASE1)
- Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure (NA)
- Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder (PHASE2)
- The Efficacy and Safety of Shoulder Chuna on in Patients With Shoulder Pain Caused by Traffic Accidents (NA)
- Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without HIPEC (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Second Treatment Period CI brief — competitive landscape report
- Second Treatment Period updates RSS · CI watch RSS
- Beth Israel Deaconess Medical Center portfolio CI